Michael M. Hann

5.9k total citations · 2 hit papers
44 papers, 3.7k citations indexed

About

Michael M. Hann is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Michael M. Hann has authored 44 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Computational Theory and Mathematics and 13 papers in Organic Chemistry. Recurrent topics in Michael M. Hann's work include Computational Drug Discovery Methods (15 papers), Chemical Synthesis and Analysis (10 papers) and Click Chemistry and Applications (9 papers). Michael M. Hann is often cited by papers focused on Computational Drug Discovery Methods (15 papers), Chemical Synthesis and Analysis (10 papers) and Click Chemistry and Applications (9 papers). Michael M. Hann collaborates with scholars based in United Kingdom, United States and Sweden. Michael M. Hann's co-authors include Andrew R. Leach, Gavin Harper, György M. Keserű, Duncan B. Judd, Xiao Qing Lewell, Steve P. Watson, William G. Richards, P. John Thomas, P. D. KENNEWELL and Peter G. Sammes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Michael M. Hann

43 papers receiving 3.5k citations

Hit Papers

Molecular Complexity and Its Impact on the Probability of... 1998 2026 2007 2016 2001 1998 200 400 600

Peers

Michael M. Hann
Michal Vieth United States
Douglas B. Kitchen United States
Ingo Muegge United States
Paul S. Charifson United States
Simon J. Teague United Kingdom
Guy W. Bemis United States
Charles H. Reynolds United States
Steven L. Dixon United States
A. Geoffrey Skillman United States
Michal Vieth United States
Michael M. Hann
Citations per year, relative to Michael M. Hann Michael M. Hann (= 1×) peers Michal Vieth

Countries citing papers authored by Michael M. Hann

Since Specialization
Citations

This map shows the geographic impact of Michael M. Hann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Hann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Hann more than expected).

Fields of papers citing papers by Michael M. Hann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Hann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Hann. The network helps show where Michael M. Hann may publish in the future.

Co-authorship network of co-authors of Michael M. Hann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Hann. A scholar is included among the top collaborators of Michael M. Hann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Hann. Michael M. Hann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grant, Emma K., Francesca Zappacosta, Lee J. Edwards, et al.. (2023). Reactive fragments targeting carboxylate residues employing direct to biology, high-throughput chemistry. RSC Medicinal Chemistry. 14(4). 671–679. 11 indexed citations
2.
Schneider, Melanie, Chris J. Radoux, David Ochoa, et al.. (2021). The PROTACtable genome. Nature Reviews Drug Discovery. 20(10). 789–797. 162 indexed citations
3.
Hann, Michael M.. (2020). Lessons in Transcellular Membrane Transport Re-Learned. Journal of Pharmaceutical Sciences. 110(1). 548–551. 2 indexed citations
4.
Grant, Emma K., David J. Fallon, Michael M. Hann, et al.. (2020). A Photoaffinity‐Based Fragment‐Screening Platform for Efficient Identification of Protein Ligands. Angewandte Chemie International Edition. 59(47). 21096–21105. 42 indexed citations
5.
Stevers, Loes M., Eline Sijbesma, Maurizio Botta, et al.. (2017). Modulators of 14-3-3 Protein–Protein Interactions. Journal of Medicinal Chemistry. 61(9). 3755–3778. 210 indexed citations
6.
Liddle, John, Margaret Binnie, Anne Bouillot, et al.. (2017). The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis. Bioorganic & Medicinal Chemistry Letters. 27(9). 2023–2028. 9 indexed citations
7.
Gordon, Laurie, Per Artursson, Michael M. Hann, et al.. (2015). Direct Measurement of Intracellular Compound Concentration by RapidFire Mass Spectrometry Offers Insights into Cell Permeability. SLAS DISCOVERY. 21(2). 156–164. 43 indexed citations
8.
Chan, Pan F., Srikannathasan Velupillai, Jianzhong Huang, et al.. (2015). Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin. Nature Communications. 6(1). 10048–10048. 122 indexed citations
9.
Hann, Michael M. & Graham L. Simpson. (2014). Intracellular drug concentration and disposition – The missing link?. Methods. 68(2). 283–285. 33 indexed citations
10.
Chae, Pil Seok, Shweta Singh, Danuta E. Mossakowska, et al.. (2013). Unlocking the secrets of the gatekeeper: Methods for stabilizing and crystallizing GPCRs. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1828(11). 2583–2591. 31 indexed citations
11.
Agrawal, Alka, Mélanie Roué, Claus Spitzfaden, et al.. (2013). Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motion. Biochemical Journal. 456(2). 263–273. 40 indexed citations
12.
Leach, Andrew R. & Michael M. Hann. (2011). Molecular complexity and fragment-based drug discovery: ten years on. Current Opinion in Chemical Biology. 15(4). 489–496. 135 indexed citations
13.
Leach, Andrew R., Michael M. Hann, Jeremy N. Burrows, & Ed Griffen. (2006). Fragment screening: an introduction. Molecular BioSystems. 2(9). 429–446. 116 indexed citations
14.
Storer, Richard, Anthony D. Baxter, Michael M. Hann, et al.. (1999). The Synthesis and Antiviral Activity of 4-Fluoro-1-β-D-ribofuranosyl-1H-pyrazole-3-carboxamide. Nucleosides and Nucleotides. 18(2). 203–216. 71 indexed citations
15.
Hornby, E J, Susan H. Brown, Michael M. Hann, et al.. (1994). Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist. Thrombosis Research. 75(3). 269–284. 5 indexed citations
16.
Essex, Jonathan W., Michael M. Hann, & William G. Richards. (1994). Molecular dynamics simulation of a hydrated phospholipid bilayer. Philosophical Transactions of the Royal Society B Biological Sciences. 344(1309). 239–260. 54 indexed citations
17.
Robinson, Alexander, William G. Richards, P. John Thomas, & Michael M. Hann. (1994). Head group and chain behavior in biological membranes: a molecular dynamics computer simulation. Biophysical Journal. 67(6). 2345–2354. 51 indexed citations
18.
Hornby, E J, et al.. (1993). Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs. Thrombosis Research. 72(3). 231–245. 11 indexed citations
19.
Humber, David C., Mark J. Bamford, Richard C. Bethell, et al.. (1993). A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationships. Journal of Medicinal Chemistry. 36(21). 3120–3128. 15 indexed citations
20.
Wonacott, Alan J., Roger Cooke, Michael M. Hann, et al.. (1993). A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: structural and modeling studies. Journal of Medicinal Chemistry. 36(21). 3113–3119. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026